Elmeligie S - Search Results

1

New 3-Substituted-2-(4-hydroxyanilino)pyridine Derivatives: Synthesis, Antitumor Activity, and Tubulin Polymerization Inhibition.

Elmeligie S, Khalil NA, Ahmed EM, Emam SH. Elmeligie S, et al. Arch Pharm (Weinheim). 2017 Feb;350(2). doi: 10.1002/ardp.201600256. Epub 2017 Feb 2. Arch Pharm (Weinheim). 2017. PMID: 28150327

2

Synthesis of New N¹-Substituted-5-aryl-3-(3,4,5-trimethoxyphenyl)-2-pyrazoline Derivatives as Antitumor Agents Targeting the Colchicine Site on Tubulin.

Elmeligie S, Khalil NA, Ahmed EM, Emam SH, Zaitone SA. Elmeligie S, et al. Biol Pharm Bull. 2016;39(10):1611-1622. doi: 10.1248/bpb.b16-00277. Biol Pharm Bull. 2016. PMID: 27725438 Free article.

3

Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds.

El-Meligie S, Taher AT, Kamal AM, Youssef A. El-Meligie S, et al. Eur J Med Chem. 2017 Jan 27;126:52-60. doi: 10.1016/j.ejmech.2016.09.099. Epub 2016 Oct 1. Eur J Med Chem. 2017. PMID: 27744186

4

Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues.

Elmeligie S, Taher AT, Khalil NA, El-Said AH. Elmeligie S, et al. Arch Pharm Res. 2017 Jan;40(1):13-24. doi: 10.1007/s12272-016-0849-y. Epub 2016 Oct 17. Arch Pharm Res. 2017. PMID: 27747473

5

Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity.

Elmeligie S, Ahmed EM, Abuel-Maaty SM, Zaitone SA, Mikhail DS. Elmeligie S, et al. Chem Pharm Bull (Tokyo). 2017;65(3):236-247. doi: 10.1248/cpb.c16-00532. Chem Pharm Bull (Tokyo). 2017. PMID: 28250345 Free article.

6

Design, Synthesis and Screening of 4,6-Diaryl Pyridine and Pyrimidine Derivatives as Potential Cytotoxic Molecules.

Abd Elhameid MK, Ryad N, Al-Shorbagy MY, Mohammed MR, Ismail MM, El Meligie S. Abd Elhameid MK, et al. Chem Pharm Bull (Tokyo). 2018 Oct 1;66(10):939-952. doi: 10.1248/cpb.c18-00269. Epub 2018 Aug 14. Chem Pharm Bull (Tokyo). 2018. PMID: 30111667 Free article.

7

Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition.

Elmeligie S, Aboul-Magd AM, Lasheen DS, Ibrahim TM, Abdelghany TM, Khojah SM, Abouzid KAM. Elmeligie S, et al. J Enzyme Inhib Med Chem. 2019 Dec;34(1):1347-1367. doi: 10.1080/14756366.2019.1642883. J Enzyme Inhib Med Chem. 2019. PMID: 31322015 Free PMC article.

8

In vivo- and in silico-driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors.

Abulkhair HS, Elmeligie S, Ghiaty A, El-Morsy A, Bayoumi AH, Ahmed HEA, El-Adl K, Zayed MF, Hassan MH, Akl EN, El-Zoghbi MS. Abulkhair HS, et al. Among authors: elmeligie s. Arch Pharm (Weinheim). 2021 May;354(5):e2000449. doi: 10.1002/ardp.202000449. Epub 2021 Feb 9. Arch Pharm (Weinheim). 2021. PMID: 33559320

9

Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme.

Swedan HK, Kassab AE, Gedawy EM, Elmeligie SE. Swedan HK, et al. Among authors: elmeligie se. J Enzyme Inhib Med Chem. 2023 Dec;38(1):118-137. doi: 10.1080/14756366.2022.2136172. J Enzyme Inhib Med Chem. 2023. PMID: 36305290 Free PMC article.

10

Topoisomerase II inhibitors design: Early studies and new perspectives.

Swedan HK, Kassab AE, Gedawy EM, Elmeligie SE. Swedan HK, et al. Among authors: elmeligie se. Bioorg Chem. 2023 Jul;136:106548. doi: 10.1016/j.bioorg.2023.106548. Epub 2023 Apr 20. Bioorg Chem. 2023. PMID: 37094479 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters